Tranilast
Specifications
53902-12-8CAS Number
621-256-5EC Number
2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acidIUPAC Name
C18H17NO5Chemical Formula
327.3 g/molMolecular Weight
tranilast; 53902-12-8; Rizaben; Tranilastum; N-(3,4-Dimethoxycinnamoyl)anthranilic acid; MK-341; HVF50SMY6E; NSC-758970; 2-((3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic acid; 2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino]benzoic Acid; CHEBI:77572; BENZOIC ACID, 2-((3-(3,4-DIMETHOXYPHENYL)-1-OXO-2-PROPENYL)AMINO)-; 2-{[(2e)-3-(3,4-Dimethoxyphenyl)prop-2-Enoyl]amino}benzoic Acid; 2-(((2E)-3-(3,4-Dimethoxyphenyl)prop-2-enoyl)amino)benzoic acid; Benzoic acid, 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino]-; RefChem:898664; MK341; N (3', 4'-dimethoxycinnamoyl) anthranilic acid (N-5'); 1 N-(3'-4'-dimethoxycinnamoyl) anthranilic acid (N-5'), N(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'); trans-Tranilast; 70806-55-2; MK 341; (E)-2-(3-(3,4-dimethoxyphenyl)acrylamido)benzoic acid; 2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid; SB-252218; MFCD00864787; 53902-17-3; Tranilast (trans-); 2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propen-1-yl]amino]benzoic Acid; MLS000028468; (E)-2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid; 2-(3-(3,4-dimethoxyphenyl)acrylamido)benzoic acid; NCGC00018185-05; SMR000058373; 2-[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enamido]benzoic acid; Tranilastum [INN-Latin]; 2-[3-(3,4-Dimethoxyphenyl)acrylamido]benzoic Acid; Tranilast [USAN:INN:JAN]; Tranpro; Rizaben (TN); SR-01000003092; n-(3',4'-dimethoxycinnamoyl) anthranilic acid; UNII-HVF50SMY6E; (E)-2-[3-(3,4-Dimethoxyphenyl)acrylamido]benzoic Acid; Anthranilic acid, N-(3,4-dimethoxycinnamoyl)-; MK 341;SB 252218; NU-3450; Tranilast Impurity 31; TRANILAST [INN]; TRANILAST [JAN]; TRANILAST [MI]; TRANILAST [USAN]; Opera_ID_1657; 2-(3,4-Dimethoxycinnamoylamino)benzoic Acid; TRANILAST [MART.]; T 0318; TRANILAST [WHO-DD]; 2-[3-(3,4-dimethoxyphenyl)prop-2-enoylamino]benzoic acid; Lopac0_001193; SCHEMBL29875; BSPBio_003561; MLS000759509; MLS001065902; MLS001077269; MLS001424045; MLS002207030; MLS006010043; SPECTRUM1505333; Tranilast (SB 252218); Tranilast - Bio-X trade mark; CHEMBL415324; DTXCID403693; GTPL6326; orb1224176; orb1305844; Tranilast (JP18/USAN/INN); SCHEMBL29366319; SCHEMBL29556872; SCHEMBL30352530; Tranilast (SB 252218)?; BDBM21613; CHEBI:92320; GLXC-06795; HMS2051F05; HMS2089L07; HMS2094I21; HMS2230F18; HMS3263P07; HMS3412G17; HMS3648A16; HMS3676G17; HMS3713J04; HMS5079E06; HMS5085D15; Pharmakon1600-01505333; HY-B0195; Tox21_110836; Tox21_501193; AC-940; CCG-39992; HB1201; HSCI1_000076; MSK164472; NSC758970; s5871; SBB052710; 2-({(2E)-3-[3,4-bis(methyloxy)phenyl]prop-2-enoyl}amino)benzoic acid; AKOS002841076; Tranilast, >=98% (HPLC), powder; DB07615; EBC-457041; FD28369; KS-1193; LP01193; NC00171; NSC 758970; SDCCGSBI-0051160.P004; NCGC00018185-04; NCGC00018185-06; NCGC00018185-08; NCGC00018185-09; NCGC00018185-10; NCGC00018185-20; NCGC00018185-23; NCGC00018185-25; NCGC00018185-26; NCGC00021458-04; NCGC00021458-05; NCGC00021458-07; NCGC00261878-01; AC-35254; BD164491; DA-68308; N-5'; SY030160; SY259979; SBI-0051160.P003; CAS-53902-12-8; EU-0101193; NS00068062; S1439; SW197551-3; T2270; T6902; N-(3 ,4 -dimethoxycinnamoyl)anthranilic acid; N-(3,4-Dimethoxycinna moyl)-anthranilic acid; D02027; G60930; M02569; AB00382987-18; AB00382987-19; AB00382987_21; Q2325594; SR-01000003092-2; SR-01000003092-4; SR-01000003092-9; BRD-K17849083-001-02-2; BRD-K17849083-001-03-0; BRD-K17849083-001-29-5; BRD-K17849083-001-30-3; BRD-K17849083-001-31-1; BRD-K17849083-001-32-9; BRD-K19533706-001-01-9; Q27164069; SR-01000003092-16; 2-[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoylamino]benzoic acid; 2-[[3-(3,4-dimethoxyphenyl)-1-oxoprop-2-enyl]amino]benzoic acid; Benzoic acid,2-[[3-(3-methoxy-4-propoxyphenyl)-1-oxo-2-propenyl]amino]-; tranilast; 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino] benzoic acid; 2,2'-((3,4-bis(3,4-dimethoxyphenyl)cyclobutane-1,2-dicarbonyl)bis(azanediyl))dibenzoic acid; D27Synonyms
